Negative predictive value of the Duke criteria for infective endocarditis

The American Journal of Cardiology
G A DoddsJ Kisslo

Abstract

With use of new Duke criteria, 405 episodes of suspected endocarditis were previously classified as "definite," "possible," or "rejected" endocarditis. To determine the negative predictive value of the Duke clinical criteria for the classification of suspected endocarditis, chart review and follow-up were performed for the 52 episodes in which the diagnosis of endocarditis was rejected. Three of 52 episodes were reclassified to possible endocarditis; 49 episodes in 48 patients met the criteria for rejected endocarditis. Of these 49 episodes, 31 (63%) had a firm alternate diagnosis other than endocarditis, 17 (35%) had resolution of the clinical syndrome leading to the suspicion of endocarditis with < or = 4 days of antibiotics, and 1 patient had no evidence of endocarditis at surgery. Echocardiograms recorded in 3 patients with rejected endocarditis had evidence of oscillating valvular masses, and blood cultures were positive in 13 episodes; none of these patients had evidence of endocarditis at follow-up. Follow-up or outcome information was available in all 49 episodes. Excluding the 5 in-hospital deaths, mean duration (+/- SD) of follow-up was 39.9 +/- 28.8 months (range 0.5 to 108.0); in living patients, mean time to final ...Continue Reading

References

Nov 1, 1977·The Central African Journal of Medicine
Apr 1, 1977·Proceedings of the Royal Society of Medicine·D Isenberg
Oct 1, 1986·The Journal of Infectious Diseases·J I SussmanR A Pizzarello
Apr 1, 1981·Annals of Internal Medicine·C F Von ReynC S Crumpacker
Aug 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F C von ReynC S Crumpacker
Mar 1, 1994·The American Journal of Medicine·A S BayerS M Shapiro
May 1, 1994·The American Journal of Cardiology·J A BerlinD Kaye

❮ Previous
Next ❯

Citations

Jan 17, 2004·Lancet·Philippe Moreillon, Yok-Ai Que
Apr 10, 2009·Internal and Emergency Medicine·Matjaz JerebTatjana Lejko Zupanc
Sep 1, 1999·The Journal of Infection·F K Gould
Nov 30, 2000·Current Infectious Disease Reports·A L ChamisG R Corey
Jan 31, 2008·Der Internist·D Horstkotte, C Piper
Jan 17, 2002·The New England Journal of Medicine·E Mylonakis, S B Calderwood
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S LiG R Corey
Jul 21, 2001·International Journal of Antimicrobial Agents·Y CetinkayaS Unal
Jul 24, 2003·Cardiology Clinics·Michael H Crawford, David T Durack
Jul 24, 2003·Cardiology Clinics·Molly SachdevJames G Jollis
Jul 3, 2002·Infectious Disease Clinics of North America·Molly SachdevJames G Jollis
Oct 10, 2002·Infectious Disease Clinics of North America·Patricia D Brown, Donald P Levine
Aug 28, 2004·Expert Opinion on Pharmacotherapy·Leonardo CalzaFrancesco Chiodo
Mar 9, 2007·Orvosi hetilap·Olga Hajnalka BálintGyula Prinz
Jun 11, 1999·Journal of the American College of Cardiology·G HabibR Luccioni
Oct 5, 2001·Current Problems in Cardiology·L MauriP T O'Gara
Mar 1, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·David T. Durack
Feb 8, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E E HillW E Peetermans
Feb 21, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R. RognonP. Francioli
Aug 1, 1996·Cardiology Clinics·A S Bayer
Jul 22, 2006·Scandinavian Journal of Infectious Diseases·Cao Thach Tran, Keld Kjeldsen
Sep 17, 2015·Circulation·Larry M BaddourUNKNOWN American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular
Feb 16, 2006·Nuclear Medicine Communications·Giuseppe Lucio CasciniLuigi Mansi
May 19, 2006·FEMS Immunology and Medical Microbiology·Philippe Brouqui, Didier Raoult
Aug 19, 2007·Critical Care Medicine·Steven J Lester, Susan Wilansky
Feb 28, 2009·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·S RekikS Kammoun
Dec 1, 2017·The Tohoku Journal of Experimental Medicine·Hiroki NamikawaHiroshi Kakeya
Mar 13, 2008·Journal of Cardiovascular Medicine·Enrico CecchiRita Trinchero
Jul 16, 2003·Medicine·Maria WernerHarriet Hogevik
Mar 23, 2019·BMJ : British Medical Journal·David Hamilton, Karen Lipscomb
Feb 25, 2017·Current Infectious Disease Reports·Bernard IungXavier Duval
Oct 6, 2017·Frontiers in Cardiovascular Medicine·Rayan Jo RachwanRachoin Rachoin
Jul 3, 2021·Microorganisms·Carmela Del GiudiceGiuseppe Rengo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
R E NettlesD J Sexton
European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Mario LusiniElvio Covino
© 2021 Meta ULC. All rights reserved